Glycosylated walnut protein isolate improves the stability of walnut oil microcapsules, suggesting a new application for walnut by-products.
In this study, walnut protein isolate (WNPI) was glycosylated with maltodextrin (M) to prepare a glycosylated protein conjugate (WNPI-M) and its conformational and functional properties were comprehensively analyzed. Subsequently, WNPI-M was employed as a wall material to fabricate walnut oil microcapsules, and the impact of WNPI-M on microcapsule stability was systematically investigated. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and multiple spectroscopic techniques confirmed that glycosylation with M induced significant modifications in WNPI's molecular structure and morphology. The glycosylation profoundly enhanced WNPI's functional properties: solubility at neutral pH increased to 76.94%, emulsifying activity reached 18.16 m 2 /g, and emulsion stability was extended to 244.74 min. Concurrently, the antioxidant capacity of the conjugate was markedly improved. When applied to microencapsulation, WNPI-M demonstrated superior performance in solubility, moisture content, and storage stability of walnut oil microcapsules. These findings substantiate the potential of WNPI-M as a novel, clean-label, and “same-source” wall material for microencapsulation, providing a viable strategy for the high-value utilization of walnut processing by-products. • WNPI-M conjugate was prepared by glycosylation reaction. • The covalent binding of M changed the molecular structure and morphology of WNPI. • M enhanced the physical and chemical properties of WNPI. • The encapsulation efficiency and physicochemical properties of walnut oil microcapsules were improved by using WNPI-M as the wall material of microcapsules.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: